Hemeo’s core technology is a computational model of the blood coagulation system that has been validated with laboratory data from thousands of people.
Supplied with a single patient’s laboratory data, the model can make personalized thrombosis and bleeding risk predictions and personalized treatment recommendations.
The insight provided by Hemeo’s intuitive clinical decision support software provides physicians with such patient specific guidance that it has the power to significantly reduce the number of bleeding and thrombosis instances in ICU patients.